InsiderClue
Stocks · Health care · Pharmaceutical Preparations

LIFECORE BIOMEDICAL, INC. DE

LFCR Clue Score33
United States Fiscal year ends May CIK 0001005286
$6.45 +0.31% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $6.45 −32.03% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2017Revenue469.8Operating income14.7Net income10.6EPS, diluted0.38Fiscal year 2018Revenue524.2 +11.6%Operating income13.6Net income24.8 +134.5%EPS, diluted0.89 +134.2%Fiscal year 2019Revenue557.6 +6.4%Operating income5.5Net income0.4 −98.3%EPS, diluted0.01 −98.9%Fiscal year 2020Revenue160.1 −71.3%Operating income−25.9Net income−38.2 −9,392.2%EPS, diluted−1.31 −13,200.0%Fiscal year 2021Revenue100.9 −37.0%Operating income−8.8Net income−32.3EPS, diluted−1.10Fiscal year 2022Revenue111.3 +10.3%Operating income−11.8Net income−116.7EPS, diluted−3.97Fiscal year 2023Revenue103.3 −7.2%Operating income−21.8Net income−99.6EPS, diluted−3.32Fiscal year 2024Revenue128.3 +24.2%Operating income−8.8Net income12.0EPS, diluted0.33Fiscal year 2025Revenue128.9 +0.5%Operating income−17.2Net income−38.7 −422.3%EPS, diluted−1.27 −484.8%
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 469.8 524.2 557.6 160.1 100.9 111.3 103.3 128.3 128.9
Growth +11.6% +6.4% −71.3% −37.0% +10.3% −7.2% +24.2% +0.5%
Operating income 14.7 13.6 5.5 −25.9 −8.8 −11.8 −21.8 −8.8 −17.2
Net income 10.6 24.8 0.4 −38.2 −32.3 −116.7 −99.6 12.0 −38.7
Growth +134.5% −98.3% −9,392.2% −422.3%
EPS, diluted 0.38 0.89 0.01 −1.31 −1.10 −3.97 −3.32 0.33 −1.27
Growth +134.2% −98.9% −13,200.0% −484.8%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2017Gross margin16.9%Operating margin3.1%Net margin2.3%Free cash flow margin1.5%Fiscal year 2018Gross margin14.9%Operating margin2.6%Net margin4.7%Free cash flow margin−2.6%Fiscal year 2019Gross margin14.5%Operating margin1.0%Net margin0.1%Free cash flow margin−5.1%Fiscal year 2020Gross margin24.6%Operating margin−16.2%Net margin−23.9%Free cash flow margin−18.3%Fiscal year 2021Gross margin38.6%Operating margin−8.7%Net margin−32.0%Free cash flow margin−2.8%Fiscal year 2022Gross margin35.1%Operating margin−10.6%Net margin−104.9%Free cash flow margin−43.9%Fiscal year 2023Gross margin27.1%Operating margin−21.1%Net margin−96.4%Fiscal year 2024Gross margin32.6%Operating margin−6.9%Net margin9.4%Free cash flow margin−14.1%Fiscal year 2025Gross margin31.3%Operating margin−13.4%Net margin−30.0%Free cash flow margin−10.6%
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 16.9% 14.9% 14.5% 24.6% 38.6% 35.1% 27.1% 32.6% 31.3%
Operating margin 3.1% 2.6% 1.0% −16.2% −8.7% −10.6% −21.1% −6.9% −13.4%
Net margin 2.3% 4.7% 0.1% −23.9% −32.0% −104.9% −96.4% 9.4% −30.0%
Free cash flow margin 1.5% −2.6% −5.1% −18.3% −2.8% −43.9% n/a −14.1% −10.6%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow29.8Capital expenditure−23.0Free cash flow6.8Fiscal year 2018Operating cash flow19.8Capital expenditure−33.6Free cash flow−13.8 −302.1%Fiscal year 2019Operating cash flow16.0Capital expenditure−44.7Free cash flow−28.7Fiscal year 2020Operating cash flow−17.0Capital expenditure−12.2Free cash flow−29.3Fiscal year 2021Operating cash flow16.5Capital expenditure−19.3Free cash flow−2.8Fiscal year 2022Operating cash flow−22.6Capital expenditure−26.2Free cash flow−48.8Fiscal year 2023Operating cash flow−17.4Fiscal year 2024Operating cash flow0.3Capital expenditure−18.4Free cash flow−18.1Fiscal year 2025Operating cash flow−0.2Capital expenditure−13.4Free cash flow−13.6
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 29.8 19.8 16.0 −17.0 16.5 −22.6 −17.4 0.3 −0.2
Capital expenditure −23.0 −33.6 −44.7 −12.2 −19.3 −26.2 n/a −18.4 −13.4
Free cash flow 6.8 −13.8 −28.7 −29.3 −2.8 −48.8 n/a −18.1 −13.6
Growth −302.1%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2017Cash6.0Total debt47.2Net cash (debt)−41.2Shareholders’ equity226.6Debt to equity0.21Fiscal year 2018Cash2.9Total debt42.3Net cash (debt)−39.4Shareholders’ equity252.6Debt to equity0.17Fiscal year 2019Cash1.1Total debt97.0Net cash (debt)−95.9Shareholders’ equity270.1Debt to equity0.36Fiscal year 2020Cash0.4Total debt112.9Net cash (debt)−112.6Shareholders’ equity229.8Debt to equity0.49Fiscal year 2021Cash0.8Total debt164.9Net cash (debt)−164.1Shareholders’ equity201.9Debt to equity0.82Fiscal year 2022Cash1.0Total debt98.2Net cash (debt)−97.2Shareholders’ equity87.8Debt to equity1.12Fiscal year 2023Cash19.1Total debt84.8Net cash (debt)−65.7Shareholders’ equity−4.2Fiscal year 2024Cash8.5Total debt101.8Net cash (debt)−93.3Shareholders’ equity11.3Debt to equity8.99Fiscal year 2025Cash8.3Total debt133.9Net cash (debt)−125.6Shareholders’ equity1.3Debt to equity100.20
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 6.0 2.9 1.1 0.4 0.8 1.0 19.1 8.5 8.3
Total debt 47.2 42.3 97.0 112.9 164.9 98.2 84.8 101.8 133.9
Net cash (debt) −41.2 −39.4 −95.9 −112.6 −164.1 −97.2 −65.7 −93.3 −125.6
Shareholders’ equity 226.6 252.6 270.1 229.8 201.9 87.8 −4.2 11.3 1.3
Debt to equity 0.21 0.17 0.36 0.49 0.82 1.12 n/a 8.99 100.20

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending May, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 28 May 2017 FY2018 27 May 2018 FY2019 26 May 2019 FY2020 31 May 2020 FY2021 30 May 2021 FY2022 29 May 2022 FY2023 28 May 2023 FY2024 26 May 2024 FY2025 25 May 2025
Revenue and profit
469.8 524.2 557.6 160.1 100.9 111.3 103.3 128.3 128.9
Growth +11.6% +6.4% −71.3% −37.0% +10.3% −7.2% +24.2% +0.5%
390.6 445.9 476.6 120.7 61.9 72.2 75.3 86.4 88.6
79.2 78.3 81.0 39.4 38.9 39.1 28.0 41.9 40.3
Growth −1.1% +3.4% −51.4% −1.1% +0.3% −28.4% +49.5% −3.7%
9.5 12.8 11.5 7.6 6.7 7.8 8.7 8.6 8.3
52.5 52.0 62.1 40.7 27.7 34.7 39.0 40.5 44.0
14.7 13.6 5.5 −25.9 −8.8 −11.8 −21.8 −8.8 −17.2
Growth −7.4% −59.7% −572.6%
14.2 16.4 3.6 −30.6 −29.8 −20.7 −63.9 9.5 −38.7
4.0 −9.4 1.5 −8.8 −6.4 −5.2 0.3 0.2 0.0
10.6 24.8 0.4 −38.2 −32.3 −116.7 −99.6 12.0 −38.7
Growth +134.5% −98.3% −9,392.2% −422.3%
Per share
0.39 0.90 0.01 −1.31 −1.10 −3.97 −3.32 0.39 −1.27
0.38 0.89 0.01 −1.31 −1.10 −3.97 −3.32 0.33 −1.27
Growth +134.2% −98.9% −13,200.0% −484.8%
27.3 27.5 28.4 29.2 29.3 29.5 30.0 30.5 34.8
27.7 27.9 28.6 29.2 29.3 29.5 30.0 36.7 34.8
Growth +1.0% +2.5% +1.9% +0.5% +0.6% +1.7% +22.4% −5.0%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue shrank 4.2% a year over five years.
  • The diluted share count rose 19.4% in five years, which is dilution.
  • Operating margin is up 2.8 points on five years ago, at -13.4%.
  • A net loss in 5 of 9 years on file.